相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis
Claus Bachert et al.
ALLERGY (2020)
A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis
W. Colby Brown et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2020)
Understanding the Patient Experience of Severe, Recurrent, Bilateral Nasal Polyps: A Qualitative Interview Study in the United States and Germany
Rebecca Hall et al.
VALUE IN HEALTH (2020)
Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study
Insu Yilmaz et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Needs for Systems Approaches to Better Treat Individuals With Severe Asthma: Predicting Phenotypes and Responses to Treatments
Luc Colas et al.
FRONTIERS IN MEDICINE (2020)
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)
Reynold A. Panettieri et al.
JOURNAL OF ASTHMA AND ALLERGY (2020)
EUFOREA consensus on biologics for CRSwNP with or without asthma
Wytske J. Fokkens et al.
ALLERGY (2019)
Biological treatments for severe asthma: A major advance in asthma care
William W. Busse
ALLERGOLOGY INTERNATIONAL (2019)
Is It Time for a Patient-Centered Quality Measure of Asthma Control?
Elizabeth Herman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
Hiroaki Tsurumaki et al.
MEDICINA-LITHUANIA (2019)
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Claus Bachert et al.
LANCET (2019)
Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art
Lei Ren et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2019)
Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
Alison G. Kartush et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2019)
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
William W. Busse et al.
LANCET RESPIRATORY MEDICINE (2019)
Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma
Sean O'Quinn et al.
JOURNAL OF ASTHMA AND ALLERGY (2019)
Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma
Hae-Sim Park et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2019)
Chronic rhinosinusitis severity is associated with need for asthma-related systemic corticosteroids
K.M. Phillips et al.
RHINOLOGY (2018)
Increasing confidence in the therapeutic relevance of eosinophils in severe asthma
Marc Humbert
LANCET RESPIRATORY MEDICINE (2018)
Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies
J. Mark FitzGerald et al.
LANCET RESPIRATORY MEDICINE (2018)
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma
Eugene R. Bleecker et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis
R. J. Schlosser et al.
ALLERGY (2017)
Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre
J. van der Veen et al.
ALLERGY (2017)
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma
Parameswaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies
Mitchell Goldman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery
Paul D. Neubauer et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
J. Mark FitzGerald et al.
LANCET (2016)
Reductions in eosinophil biomarkers by benralizumab in patients with asthma
Tuyet-Hang Pham et al.
RESPIRATORY MEDICINE (2016)
Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations
Newton Li et al.
ALLERGY AND ASTHMA PROCEEDINGS (2015)
Airway Inflammation in Chronic Rhinosinusitis with Nasal Polyps and Asthma: The United Airways Concept Further Supported
Kare Hakansson et al.
PLOS ONE (2015)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Aeroallergen sensitization influences quality of life and comorbidities in patients with nasal polyposis
Ignacio Davila et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2012)
Global asthma prevalence in adults: findings from the cross-sectional world health survey
Teresa To et al.
BMC PUBLIC HEALTH (2012)
A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery
Pernilla Sahlstrand-Johnson et al.
RHINOLOGY (2011)
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
MEDI-563, a humanized anti-IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
Roland Kolbeck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Comparative clinical and airway inflammatory features of asthma with or without nasal polyposis
Lara Bilodeau et al.
RHINOLOGY (2010)
Psychometric validity of the 22-item Sinonasal Outcome Test
C. Hopkins et al.
CLINICAL OTOLARYNGOLOGY (2009)
Differentiation of chronic sinus diseases by measurement of inflammatory mediators
T. Van Zele et al.
ALLERGY (2006)
General considerations for lung function testing
MR Miller et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
EF Juniper et al.
RESPIRATORY MEDICINE (2005)
分享论文
